person · Reporting owner

White Matthew J

Disclosed activity across 2 companies

Tapewire entity: 61495
SEC CIK: 0001441755

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
LINDE PLCLIN · Entity 2835	Chief Financial Officer	March 09, 2026	March 11, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LINDE PLC

Report date March 09, 2026 · Filed March 11, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	83,094.804	Ending reported balance After 2026-03-09 transaction · row 6 6 source rows · reconciled sequence Row 1 · 2026-03-09 · Exercise / conversion · Acquired 8,136 · Balance 83,785.804 F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023. Row 2 · 2026-03-09 · Tax withholding · Disposed 3,771 · Balance 80,014.804 F2: Ordinary shares withheld from the payout to cover tax withholdings. Row 3 · 2026-03-09 · Exercise / conversion · Acquired 2,870 · Balance 82,884.804 F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023. Row 4 · 2026-03-09 · Tax withholding · Disposed 1,330 · Balance 81,554.804 F2: Ordinary shares withheld from the payout to cover tax withholdings. Row 5 · 2026-03-09 · Exercise / conversion · Acquired 2,870 · Balance 84,424.804 F3: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2023. Row 6 · 2026-03-09 · Tax withholding · Disposed 1,330 · Balance 83,094.804 F2: Ordinary shares withheld from the payout to cover tax withholdings.
Performance Share Units (ROC)SEC Table II · derivative / convertible security	Direct	8,136	Reported balance After 2026-03-09 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2026-03-09 · Grant · Acquired 8,136 · Balance 8,136 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
Performance Share Units (ROC)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-03-09 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2026-03-09 · Exercise / conversion · Disposed 8,136 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
Performance Share Units (RTSR)SEC Table II · derivative / convertible security	Direct	2,870	Reported balance After 2026-03-09 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2026-03-09 · Grant · Acquired 2,870 · Balance 2,870 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
Performance Share Units (RTSR)SEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-03-09 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2026-03-09 · Exercise / conversion · Disposed 2,870 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	3,098	Reported balance After 2026-03-09 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2026-03-09 · Grant · Acquired 3,098 · Balance 3,098 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F7: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2026-03-09 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2026-03-09 · Exercise / conversion · Disposed 2,870 · Balance 0 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F10: Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	2,728	Reported balance Holding disclosure · report date 2026-03-09 · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · Balance 2,728 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F8: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	2,625	Reported balance Holding disclosure · report date 2026-03-09 · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · Balance 2,625 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F9: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $483.62 · Expires 2036-03-09	Direct	25,259	Reported balance After 2026-03-09 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2026-03-09 · Grant · Acquired 25,259 · Balance 25,259 F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $468.77 · Expires 2035-03-07	Direct	19,156	Reported balance Holding disclosure · report date 2026-03-09 · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · Balance 19,156 F12: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $465.29 · Expires 2034-03-07	Direct	17,015	Reported balance Holding disclosure · report date 2026-03-09 · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · Balance 17,015 F13: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $354.14 · Expires 2033-03-07	Direct	18,970	Reported balance Holding disclosure · report date 2026-03-09 · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · Balance 18,970 F14: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $270.99 · Expires 2032-03-07	Direct	22,535	Reported balance Holding disclosure · report date 2026-03-09 · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · Balance 22,535 F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $253.68 · Expires 2031-03-08	Direct	34,320	Reported balance Holding disclosure · report date 2026-03-09 · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · Balance 34,320 F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09	Direct	43,695	Reported balance Holding disclosure · report date 2026-03-09 · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · Balance 43,695 F16: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $176.63 · Expires 2029-03-20	Direct	47,020	Reported balance Holding disclosure · report date 2026-03-09 · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · Balance 47,020 F17: This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27	Direct	64,665	Reported balance Holding disclosure · report date 2026-03-09 · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · Balance 64,665 F17: This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28	Direct	72,795	Reported balance Holding disclosure · report date 2026-03-09 · row 25 Instrument identity requires review; Table II rows are not merged. 1 source row Row 25 · Balance 72,795 F17: This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
Ordinary SharesSEC Table I · non-derivative	Indirect401(k)	3,096.221	Reported balance Holding disclosure · report date 2026-03-09 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 3,096.221
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	1,541.952	Reported balance Holding disclosure · report date 2026-03-09 · row 26 Instrument identity requires review; Table II rows are not merged. 1 source row Row 26 · Balance 1,541.952 F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis. F18: Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2023.

F2: Ordinary shares withheld from the payout to cover tax withholdings.

F3: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2023.

F4: Conversion to Linde plc Ordinary Shares is on a one-for-one basis.

F5: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2023-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.

F6: The PSU paid out on March 9, 2026, and the number of shares awarded and paid out was determined based upon the relative total shareholder return ("RTSR") of Linde plc from 2023-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2023.

F7: Restricted Stock Units that will vest in full and payout on or about March 9, 2029 in Linde plc Ordinary Shares on a one-for-one basis.

F8: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

F9: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

F10: Restricted Stock Units that vested in full and paid out on March 9, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

F11: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2027.

F12: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

F13: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

F14: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

F15: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

F16: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

F17: This option vested in full and became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.

F18: Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PRAXAIR INC

Report date October 31, 2018 · Filed November 01, 2018

Section 16 reporting ended · disclosed 2018-11-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Indirect401(k)	Reported balance After 2018-10-31 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2018-10-31 · Disposition to issuer · Disposed 2,732.9991 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2018-10-31 transaction · row 2 1 source row Row 2 · 2018-10-31 · Disposition to issuer · Disposed 16,611 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-10-31 · Disposition to issuer · Disposed 7,765 · Balance 0 F2: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-10-31 · Disposition to issuer · Disposed 6,054 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-10-31 · Disposition to issuer · Disposed 7,960 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2018-10-31 · Disposition to issuer · Disposed 6,191 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2018-10-31 · Disposition to issuer · Disposed 5,450 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.92 · Expires 2019-02-24	Direct	Reported balance After 2018-10-31 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2018-10-31 · Disposition to issuer · Disposed 20,290 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $76.16 · Expires 2020-02-23	Direct	Reported balance After 2018-10-31 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2018-10-31 · Disposition to issuer · Disposed 13,640 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2021-02-22	Direct	Reported balance After 2018-10-31 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2018-10-31 · Disposition to issuer · Disposed 14,845 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $109.68 · Expires 2022-02-28	Direct	Reported balance After 2018-10-31 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2018-10-31 · Disposition to issuer · Disposed 18,430 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26	Direct	Reported balance After 2018-10-31 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2018-10-31 · Disposition to issuer · Disposed 15,060 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25	Direct	Reported balance After 2018-10-31 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2018-10-31 · Disposition to issuer · Disposed 31,090 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24	Direct	Reported balance After 2018-10-31 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2018-10-31 · Disposition to issuer · Disposed 40,865 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23	Direct	Reported balance After 2018-10-31 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2018-10-31 · Disposition to issuer · Disposed 85,205 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28	Direct	Reported balance After 2018-10-31 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2018-10-31 · Disposition to issuer · Disposed 72,795 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27	Direct	Reported balance After 2018-02-27 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2018-02-27 · Disposition to issuer · Disposed 64,665 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Deferred Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2018-10-31 · Disposition to issuer · Disposed 732.164 · Balance 0 F9: Conversion to Praxair Common Stock is on a 1-for-1 basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F10: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F2: Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F9: Conversion to Praxair Common Stock is on a 1-for-1 basis.

F10: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	200	$185.02	$37,004.00	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 17 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,281 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	415	$185.02	$76,783.30	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 16 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,481 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	85	$185.02	$15,726.70	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 15 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,896 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	5	$185.02	$925.10	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 14 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,981 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	100	$185.02	$18,502.00	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 13 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,986 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	1	$185.01	$185.01	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 12 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,086 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	3,117	$185.00	$576,645.00	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 11 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,087 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	14,407	$185.01	$2,665,439.07	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 10 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,204 F2 · shares: Ordinary shares withheld from the stock option exercise to pay exercise price and taxes. Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	18,430	$109.68	$2,021,402.40	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 9 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This stock option was exercised pursuant to a Rule 10b5-1 Plan dated November 21, 2018. Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	500	$185.07	$92,535.00	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 8 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,181 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	50	$185.04	$9,252.00	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 7 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,681 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	2,050	$185.02	$379,291.00	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 6 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,731 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	150	$185.02	$27,753.00	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 5 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,781 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	1,000	$184.99	$184,990.00	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 4 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,931 Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	11,095	$185.01	$2,052,685.95	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 3 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,931 F2 · shares: Ordinary shares withheld from the stock option exercise to pay exercise price and taxes. Read SEC document
April 05, 2019 Filed Apr 8, 2019 14:09 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	14,845	$97.84	$1,452,434.80	Disclosure SEC source: 0001707925-19-000032 · edgar.xml · nonDerivative · entry 2 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This stock option was exercised pursuant to a Rule 10b5-1 Plan dated November 21, 2018. Read SEC document
March 20, 2019 Filed Mar 22, 2019 17:08 UTC	LINDE PLC LIN · Entity 2835	GrantStock Option (right to buy) · Derivative	47,020	$0.00 Strike: $176.63	$0.00	Disclosure SEC source: 0001707925-19-000020 · edgar.xml · derivative · entry 7 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,020 Underlying: Ordinary Shares · 47,020 shares Expires 2029-03-20 F4 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020. Read SEC document
March 20, 2019 Filed Mar 22, 2019 17:08 UTC	LINDE PLC LIN · Entity 2835	GrantRestricted Stock Units · Derivative	4,170	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-19-000020 · edgar.xml · derivative · entry 3 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,170 Underlying: Ordinary Shares · 4,170 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis. F1 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	GrantDeferred Stock Units · Derivative	123.57	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · derivative · entry 26 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 859.598 Underlying: Ordinary Shares · 123.57 shares Expires not disclosed F11 · derivative.exercise_price: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis. F12 · derivative.exercise_date: Deferred stock units acquired under Praxair, Inc.'s Compensation Deferral Plan ("Deferral Plan") that will be converted and paid out in Linde plc ordinary share on a one-for-one basis. F12 · derivative.expiration_date: Deferred stock units acquired under Praxair, Inc.'s Compensation Deferral Plan ("Deferral Plan") that will be converted and paid out in Linde plc ordinary share on a one-for-one basis. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Option (right to buy) · Derivative	13,640	$0.00 Strike: $76.16	$0.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · derivative · entry 17 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 13,640 shares Expires 2020-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.expiration_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRestricted Stock Units · Derivative	6,191	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · derivative · entry 13 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,191 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · derivative.exercise_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · derivative.expiration_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRestricted Stock Units · Derivative	6,054	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · derivative · entry 12 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,054 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · derivative.exercise_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · derivative.expiration_date: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	300	$175.01	$52,503.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 11 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,181 Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	407	$174.99	$71,220.93	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 10 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,481 Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	1,001	$174.98	$175,154.98	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 9 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,888 Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	2,421	$174.97	$423,602.37	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 8 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,889 Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	9,511	$175.00	$1,664,425.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 7 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,310 F4 · shares: Ordinary shares withheld from the stock option exercise to pay exercise price and taxes. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	13,640	$76.16	$1,038,822.40	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 6 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: This stock option was exercised pursuant to a Rule 10b 5-1 Plan dated November 21, 2018. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	2,869	$173.50	$497,771.50	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 5 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,181 F2 · shares: Ordinary shares withheld from RSU payout to cover tax withholdings. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	6,191	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 4 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	2,806	$173.50	$486,841.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 3 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,859 F2 · shares: Ordinary shares withheld from RSU payout to cover tax withholdings. Read SEC document
February 25, 2019 Filed Feb 27, 2019 18:21 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	6,054	$0.00	$0.00	Disclosure SEC source: 0001707925-19-000006 · edgar.xml · nonDerivative · entry 2 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. F1 · price: Ordinary shares acquired pursuant to the payout of a restricted stock unit ("RSU") grant made on February 23, 2016. Read SEC document
February 01, 2019 Filed Feb 5, 2019 18:52 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Option (right to buy) · Derivative	20,290	$0.00 Strike: $60.92	$0.00	Disclosure SEC source: 0001707925-19-000001 · edgar.xml · derivative · entry 10 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,290 shares Expires 2019-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. Read SEC document
February 01, 2019 Filed Feb 5, 2019 18:52 UTC	LINDE PLC LIN · Entity 2835	SaleOrinary Shares	7,749	$164.99	$1,278,507.51	Disclosure SEC source: 0001707925-19-000001 · edgar.xml · nonDerivative · entry 4 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,611 Read SEC document
February 01, 2019 Filed Feb 5, 2019 18:52 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	12,541	$165.00	$2,069,265.00	Disclosure SEC source: 0001707925-19-000001 · edgar.xml · nonDerivative · entry 3 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,360 F2 · shares: Shares withheld from option exercise to pay exercise price and taxes. Read SEC document
February 01, 2019 Filed Feb 5, 2019 18:52 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	20,290	$60.92	$1,236,066.80	Disclosure SEC source: 0001707925-19-000001 · edgar.xml · nonDerivative · entry 2 White Matthew J · CIK 0001441755 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Stock Option was exercized pursuant to a Rule 10b 5-1 Plan dated November 21, 2018 Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerDeferred Stock Units · Derivative	732.164	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 18 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 732.164 shares Expires not disclosed F9 · derivative.exercise_price: Conversion to Praxair Common Stock is on a 1-for-1 basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F10 · price: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. F10 · derivative.exercise_date: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. F10 · derivative.expiration_date: Deferred stock units ("DSUs") acquired by reporting person under the Praxair, Inc. Compensation Deferral Plan ("Deferral Plan"). In connection with the BCA, the DSUs have been converted into DSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	72,795	Not disclosed Strike: $118.71	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 16 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 72,795 shares Expires 2027-02-28 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F7 · price: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F7 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	85,205	Not disclosed Strike: $102.22	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 15 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 85,205 shares Expires 2026-02-23 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F6 · price: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F6 · derivative.exercise_date: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	40,865	Not disclosed Strike: $128.38	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 14 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,865 shares Expires 2025-02-24 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	31,090	Not disclosed Strike: $128.80	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 13 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,090 shares Expires 2024-02-25 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	15,060	Not disclosed Strike: $110.58	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 12 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,060 shares Expires 2023-02-26 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	18,430	Not disclosed Strike: $109.68	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 11 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,430 shares Expires 2022-02-28 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	14,845	Not disclosed Strike: $97.84	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 10 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,845 shares Expires 2021-02-22 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	13,640	Not disclosed Strike: $76.16	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 9 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,640 shares Expires 2020-02-23 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerStock Option (right to buy) · Derivative	20,290	Not disclosed Strike: $60.92	Not disclosed	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 8 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,290 shares Expires 2019-02-24 F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5 · price: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. F5 · derivative.exercise_date: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock otpion of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerRestricted Stock Units · Derivative	5,450	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 7 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,450 shares Expires not disclosed F4 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F4 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F4 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerRestricted Stock Units · Derivative	6,191	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 6 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 6,191 shares Expires not disclosed F3 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F3 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F3 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerRestricted Stock Units · Derivative	7,960	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 5 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,960 shares Expires not disclosed F4 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F4 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F4 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
October 31, 2018 Filed Nov 1, 2018 22:15 UTC	PRAXAIR INC PX · Entity 162268	Disposition to issuerRestricted Stock Units · Derivative	6,054	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0000884905-18-000078 · edgar.xml · derivative · entry 4 White Matthew J · CIK 0001441755 · Senior VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,054 shares Expires not disclosed F3 · derivative.exercise_price: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1 · kind: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F3 · derivative.exercise_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F3 · derivative.expiration_date: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.